Effects of dose modification of eribulin mesylate in patients with locally recurrent or metastatic breast cancer.
Claudio Faria
Employment or Leadership Position - Eisai
Xuan Li
Employment or Leadership Position - Eisai
Annette Powers
Employment or Leadership Position - Eisai
Linda T. Vahdat
No relevant relationships to disclose